June 4, 2020 / 11:40 AM / a month ago

BRIEF-Moleculin Reports Submission To Expand Clinical Sites In European AML Trial

June 4 (Reuters) - Moleculin Biotech Inc:

* MOLECULIN ANNOUNCES SUBMISSION TO EXPAND CLINICAL SITES IN EUROPEAN AML TRIAL

* MOLECULIN BIOTECH - SUBMITS REGULATORY REQUESTS TO OPEN TWO ADDITIONAL CLINICAL SITES IN POLAND

* MOLECULIN BIOTECH - ASSUMING REQUESTS ARE GRANTED, EXPECT ADDITIONAL SITES TO BEGIN RECRUITING IN Q3 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below